Aspen Aerogels (NYSE:ASPN) Price Target Lowered to $3.00 at Roth Mkm

Aspen Aerogels (NYSE:ASPN) had its price objective decreased by Roth Mkm from $6.00 to $3.00 in a research note published on Thursday,Benzinga reports. Roth Mkm currently has a buy rating on the construction company’s stock.

ASPN has been the subject of a number of other research reports. Zacks Research upgraded Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 15th. Barclays decreased their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research report on Friday, November 7th. TD Cowen lowered their price target on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a report on Thursday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. Finally, Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Three investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $4.50.

Aspen Aerogels Trading Up 22.2%

NYSE ASPN opened at $3.14 on Thursday. The stock’s 50 day moving average is $3.32 and its 200 day moving average is $5.07. The firm has a market capitalization of $259.51 million, a PE ratio of -0.66 and a beta of 2.99. The company has a quick ratio of 3.33, a current ratio of 3.94 and a debt-to-equity ratio of 0.28. Aspen Aerogels has a twelve month low of $2.30 and a twelve month high of $9.78.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.07). Aspen Aerogels had a negative return on equity of 13.07% and a negative net margin of 143.69%.The company had revenue of $41.34 million during the quarter, compared to analysts’ expectations of $44.25 million. During the same quarter in the previous year, the company earned $0.14 EPS. The business’s quarterly revenue was down 66.4% on a year-over-year basis. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. Research analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. Peregrine Investment Management Inc. bought a new stake in Aspen Aerogels during the third quarter valued at $4,176,000. Y Intercept Hong Kong Ltd acquired a new stake in shares of Aspen Aerogels in the 2nd quarter worth about $484,000. SG Americas Securities LLC raised its holdings in shares of Aspen Aerogels by 98.6% during the second quarter. SG Americas Securities LLC now owns 133,821 shares of the construction company’s stock valued at $792,000 after buying an additional 66,427 shares during the last quarter. Palogic Value Management L.P. raised its stake in Aspen Aerogels by 43.5% during the 2nd quarter. Palogic Value Management L.P. now owns 610,000 shares of the construction company’s stock valued at $3,611,000 after acquiring an additional 185,000 shares in the last quarter. Finally, Federated Hermes Inc. bought a new stake in shares of Aspen Aerogels during the second quarter valued at about $10,459,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels News Summary

Here are the key news stories impacting Aspen Aerogels this week:

• Positive Sentiment: Company cited a strong liquidity position and strategic actions — $158.6M year-end cash, an expected ~$37.6M GM commercial settlement in Q1 and initiation of a strategic review (Piper Sandler engaged) to optimize capital structure and options, which supports near-term solvency and optionality. Read More.
• Positive Sentiment: Commercial momentum in Energy Industrial: company highlighted a North Sea subsea pipeline award, ongoing European OEM (EV) program progress and set a 20% Energy Industrial segment growth target for 2026 — signals that project pipeline and non-EV end markets could help revenue recovery. Read More.
• Positive Sentiment: Some analysts remain constructive: TD Cowen kept a “buy” rating (PT lowered to $6 but still implies large upside vs. current levels), indicating at least one major shop sees recovery potential if strategy execution improves. Read More.
• Neutral Sentiment: Roth MKM lowered its price target from $6 to $3 while retaining a “buy” rating — mixed signal: valuation expectations trimmed but the buy stance suggests upside if turnaround actions succeed. Read More.
• Negative Sentiment: Sharp earnings/revenue deterioration — Q4 revenue plunged to $41.3M (vs. $123.1M a year earlier) and GAAP net loss of $72.9M (adjusted loss still negative). The company recorded a $291.2M impairment for the year, driving a large full-year net loss. Those results materially weaken near-term fundamentals. Read More.
• Negative Sentiment: Guidance disappointed: Q1 2026 EPS guide of -$0.28 to -$0.24 and revenue guidance $35M–$40M both miss consensus (revenue vs. ~$44M), signaling continued near-term weakness and keeping pressure on margins and cash flow. Read More.
• Negative Sentiment: Investor legal risk: a shareholder law firm (Johnson Fistel) announced an investigation into potential claims tied to Aspen’s executives and investor losses — adds litigation/PR risk and can amplify selling pressure. Read More.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.